Belgian collaborative study of the in-vitro susceptibility of the Bacteroides fragilis group

The antimicrobial susceptibility of clinical isolates of the Bacteroides fragilis group obtained from nine large Belgian university and community hospitals was studied. Of the -lactam antibiotics tested, none were active against 100% of the isolates. Piperacillin was active against 93% of the strains at a breakpoint of 64 lag/ml. The percentage of isolates inhibited at 16 g/ml (and 32 g/ml) for the 7-alpha-methoxy antibiotics was: cefoxitin 84 94]; latamoxef 87 93]; and cefotetan 64 79]. B. fragilis tended to be more susceptible to all -lactams than the other members of the group.Among the non -lactam antibiotics, the resistance rate for minocycline, doxycycline, clindamycin and erythromycin (at a breakpoint of 4 g/ml) were l%, 4%, 14% and 34%, respectively. Like the -lactams, clindamycin was less active against non B. fragilis species of the group.Chloramphenicol, metronidazole and tinidazole were still active against 100% of the isolates at their breakpoint values (8 lag/ml).